Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors), Proliferation marker protein Ki-67 expression inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC44H50N8 |
InChIKeyAVQUGAAZHJLAOQ-UHFFFAOYSA-N |
CAS Registry69937-10-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lymphoma | Preclinical | China | 19 May 2025 |





